Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,043,835
-$18,257 QoQ
Shares Held
1,351
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOKF, NA holds $12,079,082 across 17 Biotechnology names. REGN ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,935 | $2,650,214 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,331 | $2,416,036 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
53,892 | $2,172,385 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,351 | $1,043,835 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
14,954 | $966,476 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
19,585 | $484,924 | |
| 7 | INVA |
Innoviva, Inc.
|
20,328 | $473,641 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
1,829 | $472,467 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,043,835 | 1,351 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,062,092 | 1,376 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $870,393 | 1,548 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,147,125 | 2,185 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,376,912 | 2,171 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,281,592 | 3,203 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,834,413 | 1,745 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,065,273 | 1,965 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $1,775,793 | 1,845 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,646,793 | 1,875 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,532,351 | 1,862 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,785,779 | 3,877 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $3,044,286 | 3,705 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,274,842 | 4,539 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,785,789 | 4,044 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,282,943 | 3,862 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $2,700,091 | 3,866 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $2,351,148 | 3,723 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $2,276,081 | 3,761 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $2,594,226 | 5,483 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $3,013,639 | 6,238 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $3,162,196 | 5,649 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $3,928,370 | 6,299 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $3,113,336 | 6,376 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||